Treatment Recommendation for Community-Acquired Pneumonia
For a healthy adult outpatient with uncomplicated CAP and no comorbidities, use amoxicillin 1 g three times daily as first-line therapy 1.
Algorithm for Choosing Between Amoxicillin and Amoxicillin-Clavulanate
Use Amoxicillin Alone If:
- No comorbidities (no chronic heart, lung, liver, or renal disease; no diabetes; no alcoholism; no malignancy; no asplenia)
- No recent antibiotic use within the past 3 months
- No risk factors for resistant pathogens
This is a strong recommendation with moderate quality evidence from the 2019 ATS/IDSA guidelines 1.
Switch to Amoxicillin-Clavulanate If Patient Has:
- Any comorbidities listed above
- Recent antibiotic exposure (within 3 months)
- Risk factors for β-lactamase-producing organisms
For these patients, use amoxicillin-clavulanate 875 mg/125 mg twice daily plus a macrolide (azithromycin or clarithromycin) or doxycycline 1.
Evidence Supporting This Approach
The 2019 ATS/IDSA guidelines explicitly differentiate treatment based on comorbidity status 1. High-dose amoxicillin has demonstrated efficacy even for inpatient CAP despite lacking atypical coverage, with a strong safety track record 1. The guidelines note that RCTs show no mortality or treatment failure differences between antibiotic regimens, but amoxicillin is preferred for uncomplicated cases due to its narrow spectrum and antimicrobial stewardship benefits.
Recent research reinforces this distinction: prior antibiotic use within 3 months is the only independent predictor of amoxicillin-clavulanate resistance 2. In patients without recent antibiotic exposure, amoxicillin-clavulanate susceptibility reaches 90.9% 2. A 2026 systematic review found no evidence of differential effectiveness between amoxicillin and amoxicillin-clavulanate for clinical resolution (OR 1.04; 95% CI 0.64-1.70) 3.
Critical Pitfalls to Avoid
Do not use amoxicillin-clavulanate routinely in healthy patients without comorbidities. This represents unnecessary broad-spectrum coverage and increases selective pressure for resistance. Recent ICU data shows that third-generation cephalosporins (and by extension, broader agents) are frequently overused when amoxicillin-clavulanate would suffice - 80% of 3GC prescriptions were unjustified 4.
Do not substitute two 250 mg/125 mg tablets for one 500 mg/125 mg tablet - they contain different amounts of clavulanic acid and are not interchangeable 5.
Take at the start of meals to enhance clavulanate absorption and minimize GI intolerance 5.
Dosing Specifics
- Amoxicillin: 1 g every 8 hours 1
- Amoxicillin-clavulanate: 875 mg/125 mg every 12 hours OR 500 mg/125 mg every 8 hours for respiratory infections 5
The FDA label confirms these are appropriate doses for lower respiratory tract infections 5, 6.